In this study, the changes of NF‐κB‐p65 expressions of the disease course, from occurrence of colitis to reduced inflammation activity, could be accurately identified by target CEUS, and the signal intensity within the lesions was much higher than conventional CEUS, implying the high binding rate of target MBs and local tissues. The gene discussed is NFKB1; the disease is colitis.